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Abstract Fibromodulin and lumican are closely related mem-
bers of the extracellular matrix leucine-rich repeat glycoprotein/
proteoglycan family. Similar to decorin, another member of this
protein family, they bind to fibrillar collagens and function in the
assembly of the collagen network in connective tissues. We have
studied the binding of recombinant fibromodulin, lumican and
decorin, expressed in mammalian cells, to collagen type I. Using
a collagen fibril formation/sedimentation assay we show that
fibromodulin inhibits the binding of lumican, and vice versa.
Fibromodulin and lumican do not affect the binding of decorin to
collagen, nor does decorin inhibit the binding of fibromodulin or
lumican. Binding competition experiments and Scatchard plot
analysis indicate that fibromodulin binds to collagen type I with
higher affinity than lumican.
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1. Introduction
Fibromodulin [1], lumican [2], and decorin [3] belong to the
family of leucine-rich repeat (LRR) glycoproteins/proteogly-
cans, which includes about 10 members found in extracellular
matrices [4]. All the members have an overall similar struc-
ture, which can be divided into three main structural domains.
The N-terminal domains are least conserved, but all members
contain four conserved cysteine residues involved in intra-
chain disul¢de bonds [5]. Frequently this domain is negatively
charged due to substitutions with glycosaminoglycan chains,
as in decorin [3] and biglycan [6], or with tyrosine-sulfate
residues in ¢bromodulin [7] and most likely also in lumican.
The most pronounced amino acid sequence homology is in the
central domain, which constitute 60^80% of the total amino
acid residues containing 10 repeats of a leucine and asparagine
rich motif. This domain contains asparagine-linked carbohy-
drates. Fibromodulin and lumican have four or ¢ve potential
sites for carbohydrate substitution, depending on species [2,7^
9]. In a single ¢bromodulin molecule only two of these sites
carry keratan sulfate chains [10]. This substitution is more
variable in lumican, which is a keratan sulfate proteoglycan
primarily in the cornea [11]. The C-terminal domains in the
LRR-glycoproteins/proteoglycans are less conserved contain-
ing two cysteine residues forming an intrachain disul¢de
bond.
The extracellular matrix LRR-glycoproteins/proteoglycans
can be further divided into subfamilies based on sequence
similarities and gene organization. Decorin [3] and biglycan
[6], which both are chondroitin/dermatan-sulfate proteogly-
cans, are encoded by genes consisting of eight exons with
conserved exon/intron junctions [12]. They show 57% amino
acid sequence identity and constitute one subfamily. Fibromo-
dulin [1] and lumican [2] belong to another subfamily showing
47% amino acid sequence identity. Their genes consist of three
exons with conserved exon/intron junctions [13,14].
Fibromodulin and lumican synthesized by di¡erent species
are highly conserved. In the present study we have used bo-
vine ¢bromodulin and mouse lumican. Bovine and mouse
¢bromodulin show 93% amino acid sequence identity. The
protein is least conserved in the signal peptide sequence and
in the N-terminal domain substituted with tyrosine-sulfate
residues. This region is unlikely to be involved in the binding
to collagen, since the collagen binding site has been localized
to the C-terminal region [15]. Sequences located C-terminal of
the ¢rst cysteine residue (Cys-75) show 96% sequence identity
and the amino acid substitutions are mostly conserved (e.g.
Lys to Arg and Ser to Thr), except for a Ser to Gly mutation
(Ser171Gly).
Decorin [16], ¢bromodulin [17] and lumican [18] bind to
¢brillar collagens in vitro, thereby retarding the rate of ¢bril
formation and leading to the synthesis of thinner ¢brils [19].
This binding is mediated by the core proteins in decorin [20]
and in ¢bromodulin [15].
Fibromodulin and decorin have been shown to bind to
di¡erent sites on the collagen ¢bril. The binding of ¢bromo-
dulin can not be inhibited by decorin and vice versa [21].
Ultrastructural analysis of collagen ¢brils in tissues show
that both ¢bromodulin and decorin bind to the gap region of
the D-period in the collagen ¢bril [22].
Also in vivo the LRR-glycoproteins/proteoglycans a¡ect
collagen ¢bril formation. Decorin- and lumican-null mice
have fragile skin with reduced tensile strength [23,24].
Ultrastructural analysis of skin and tendon from these mice
show irregular and thicker than normal collagen ¢brils. In
addition the lumican-null mice show corneal opacity and the
collagen ¢brils in the cornea are also thicker than normal.
Mice lacking ¢bromodulin show irregular collagen ¢brils in
tendons, with an average thinner diameter than in wild type
mice [25]. The ¢bromodulin-null mice show a four-fold in-
crease of lumican in tendon, whereas decorin levels are un-
changed [25]. This suggested to us that lumican binds to the
same site as ¢bromodulin on collagen ¢brils and that the
absence of ¢bromodulin in ¢bromodulin-null mice allows
more lumican to bind to collagen.
In this study we show that ¢bromodulin and lumican com-
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pete for the same binding site on collagen type I ¢brils in
vitro.
2. Materials and methods
Mouse lumican cDNA was prepared from RNA isolated from
mouse tail tissue using RT-PCR, as previously described [25]. The
mRNA was converted to cDNA using oligo-dT primers and reverse
transcriptase (Boehringer Mannheim). Primers for the ampli¢cation of
mouse lumican cDNA were; 5P-CGGGATCCATGAATGTATGT-
GCGTTCTCTC and 5P-CGGATATCTTAGTTAACGGTGATTT-
CATTG (GenBank accession number AF013262). The PCR product,
representing full length mouse lumican cDNA, was subjected to nu-
cleotide sequence analysis to con¢rm the correct sequence. Bovine
¢bromodulin cDNA [1], bovine decorin cDNA [26] and the mouse
lumican cDNA were ligated in the Epstein^Barr based pCEP4 expres-
sion vector (Invitrogen, San Diego, CA, USA) and used for stable
transfection of HeLa cells as previously described [20]. This vector
replicates extrachromosomally and gives a high yield of recombinant
protein in transformed cells [27]. Cells producing ¢bromodulin, lumi-
can and decorin were cultured in serum free media (DMEM, GIBCO)
containing 0.1 mCi/ml [35S]sulfate or 20 WCi/ml [35S]Met. After incu-
bation for 24 h, culture media were collected and phenylmethylsul-
fonyl £uoride added as protease inhibitor.
Antisera against bovine ¢bromodulin [1], the N-terminal region of
mouse lumican [25] and bovine decorin [28] were used for immuno-
precipitations, as described [29]. The antisera were also used for de-
termining the concentration of recombinant glycoproteins/proteogly-
cans by ELISA, as described [25].
Immunoprecipitates were treated with N-glycosidase F to remove
Asn-linked oligosaccharides as recommended by the manufacturer
(Boehringer Mannheim). Collagen binding assays were performed as
previously described [20]. Conditioned culture media were concen-
trated about 20-fold by Centricon-30 ¢ltration (Amicon, Beverly,
MA, USA). Brie£y, 0.1 ml of concentrated medium was incubated
with 5 Wl of acid solubilized rat tail tendon collagen (3 mg/ml, Sigma).
After 5 h at 37‡C, the sample was centrifuged at 10 000Ug for 5 min,
the supernatant removed and the pellet washed once with phosphate-
bu¡ered saline. The pellet and supernatant were electrophoresed on a
SDS polyacrylamide gel [30] and the amounts of radiolabeled glyco-
protein/proteoglycan in the pellet and supernatant were determined
using a Bio Imaging Analyzer (Fuji Photo Film, Japan).
Scatchard plot analysis [31] was used to determine dissociation
constants as previously described [20].
3. Results
3.1. Characterization of recombinant ¢bromodulin and lumican
Recombinant ¢bromodulin and lumican were produced in
mammalian cells in order to study their collagen-binding
properties. An Epstein^Barr based mammalian expression
vector containing the cDNA encoding ¢bromodulin or lumi-
can was used to transform HeLa cells. Cell clones expressing
¢bromodulin or lumican were grown in the presence of
[35S]Met and the radiolabeled cell culture media were sub-
jected to immunoprecipitation. The ¢bromodulin antiserum
precipitated a 53^65 kDa glycoprotein, which after treatment
with N-glycosidase F migrated as a 42 kDa protein (Fig. 1,
lanes 1 and 2). The lumican antiserum precipitated a 52^58
kDa glycoprotein, which was reduced to 39 kDa after N-gly-
cosidase F treatment (Fig. 1, lanes 3 and 4). These molecular
weights are in agreement with those estimated from ¢bromo-
dulin cDNA (42 kDa) [1] and from lumican cDNA (39 kDa)
[2,8]. The HeLa cells expressing ¢bromodulin or lumican were
also radiolabeled with [35S]sulfate. After an approximately
20-fold concentration of the [35S]sulfate labeled media, sam-
ples were analyzed by SDS^PAGE (Fig. 1, lanes 5 and 6).
[35S]sulfate is incorporated as tyrosine-sulfates and/or keratan
sulfate in ¢bromodulin and lumican, which represent major
[35S]sulfate labeled components in the media. Digestion of
[35S]sulfate labeled cell media with N-glycosidase F show
similar results as digestion of the immunoprecipitated
[35S]Met labeled media (results not shown). The [35S]sulfate
labeled s 200 kDa product represents a chondroitin sulfate
proteoglycan, which does not interfere in the collagen binding
assay [20].
3.2. Competition experiments
The [35S]sulfate labeled HeLa-cell culture media were used
in the collagen binding analysis. Acid solubilized rat tail ten-
don collagen was allowed to form ¢brils in the presence of
[35S]sulfate labeled ¢bromodulin or lumican. We performed
inhibition assays to study the binding of ¢bromodulin, lumi-
can and decorin to collagen (Fig. 2). [35S]sulfate labeled gly-
coprotein/proteoglycan were incubated with varying amounts
of non-labeled glycoproteins/proteoglycan as competitors. The
binding of ¢bromodulin to collagen was inhibited by ¢bromo-
dulin and lumican. Also, the binding of lumican to collagen
was inhibited by ¢bromodulin and lumican. Decorin binding
to collagen type I was una¡ected by the addition of ¢bromo-
dulin or lumican and only decorin inhibited the binding. Like-
wise, decorin did not a¡ect the binding of ¢bromodulin or
lumican to collagen. Fibromodulin appears to be a more po-
tent inhibitor of collagen-binding than lumican. A three-fold
higher concentration of lumican, as compared to ¢bromodu-
lin, was required for equal inhibition of the binding of
[35S]sulfate labeled ¢bromodulin or lumican to collagen.
3.3. Scatchard plot analysis
To compare the binding of ¢bromodulin and lumican to
collagen, we performed binding assays with increasing con-
centrations of ¢bromodulin or lumican (Fig. 3). Saturation
was achieved at ¢bromodulin or lumican concentrations of
Fig. 1. Characterization of recombinant ¢bromodulin and lumican.
Immunoprecipitation of [35S]Met labeled recombinant ¢bromodulin
(lane 1) and lumican (lane 3) synthesized by transformed HeLa
cells. N-glycosidase F treatment of ¢bromodulin (lane 2) and lumi-
can (lane 4) show the core proteins. [35S]sulfate labeled culture me-
dia from HeLa cells synthesizing ¢bromodulin (lane 5) and lumican
(lane 6). The media were concentrated 20-fold prior to SDS^PAGE.
FEBS 23454 16-3-00
L. Svensson et al./FEBS Letters 470 (2000) 178^182 179
10^20 nM. The maximum binding of ¢bromodulin and lumi-
can were 0.40 and 0.34 pmol, respectively. Scatchard plot
analysis indicated the presence of low and high a⁄nity colla-
gen binding sites (Fig. 4). The ¢bromodulin binding to colla-
gen type I showed dissociation constants of 0.2 and 1.6 nM,
whereas lumican bound with dissociation constants of 0.5 and
5.4 nM.
4. Discussion
The LRR-glycoproteins/proteoglycans decorin, ¢bromodu-
lin and lumican bind to ¢brillar collagens and a¡ect the col-
lagen matrix assembly in connective tissues. Null-mutations in
the genes for decorin [23], ¢bromodulin [25] and lumican [24]
show that these LRR-glycoproteins/proteoglycans function in
the collagen ¢brillogenesis. Collagen ¢brils from these null-
mice are irregular in shape and size compared to collagen
¢brils from wild type mice. Tendons from ¢bromodulin-null
mice contain four-fold more lumican than wild type tendons.
This indicates that ¢bromodulin and lumican complete for the
same binding site on collagen type I ¢brils. Decorin and
¢bromodulin bind to separate sites on the collagen ¢bril
[21]. In this report we show that ¢bromodulin and lumican
share the same binding sites on collagen type I ¢brils, which is
di¡erent from the decorin binding site. Our results also indi-
cate that ¢bromodulin binds with higher a⁄nity to collagen
than does lumican. In the competition experiments ¢bromo-
dulin was a three-fold more potent inhibitor than lumican.
The collagen binding assays show that similar amounts of
¢bromodulin and lumican bind to collagen. At saturation
0.34^0.40 pmol of ¢bromodulin or lumican bound to approx-
imately 50 pmol collagen. Fibromodulin and lumican bind to
the surface of collagen ¢brils and the formation of large ¢brils
during the assay presumably explains the estimated ¢bromo-
dulin/lumican:collagen molar ratio 1:140. The Scatchard plot
analysis indicate low and high a⁄nity ¢bromodulin and lumi-
can collagen binding sites. The binding sites show a higher
a⁄nity for ¢bromodulin than for lumican. Previous studies of
decorin binding have also suggested at least two collagen
binding sites [20].
It has been proposed that the rapid growth of collagen
¢brils in the chick metatarsal tendon between day 16 and
Fig. 2. Inhibition of ¢bromodulin, lumican and decorin binding to collagen. A: Radiolabeled recombinant ¢bromodulin (FM), lumican (LUM)
and decorin (DEC) were incubated with acid solubilized collagen and with the indicated concentrations of non-labeled recombinant proteins as
inhibitors. After centrifugation, radiolabeled proteins bound to collagen ¢brils in the pellet (P) and non-bound in the supernatant (S) were ana-
lyzed by SDS^PAGE. Control incubations were done without inhibitor. B: The amounts of collagen ¢bril bound radiolabeled glycoproteins/
proteoglycans in the SDS-polyacrylamide gel (A) were determined using a Bio Imager analyzer after inhibition by varying concentrations of
non-labeled ¢bromodulin (a), lumican (b) and decorin (R). The inhibition curves include additional results not shown in (A).
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18 in embryonic development, is due to a di¡erential synthesis
of LRR-glycoproteins/proteoglycans [32]. Hypothetically, de-
corin, ¢bromodulin and lumican bind to small extracellular
collagen ¢bril segments leading to inactivation or activation of
the assembly into larger ¢brils. Our results support a scenario
where collagen bound lumican is replaced by ¢bromodulin
leading to tendon collagen ¢bril growth. Since ¢bromodulin
binds with higher a⁄nity than lumican to the same site on
collagen ¢brils, a change in collagen-bound LRR-glycopro-
tein/proteoglycan could be accomplished by an increase in
the ratio of ¢bromodulin/lumican synthesis. This ¢bril seg-
ment assembly hypothesis predicts that the LRR glycopro-
teins/proteoglycans are pivotal in determining the structure
of the ¢nal collagen ¢bril. Indeed, lumican is abundant in
cornea, which has very thin collagen ¢brils. Fibromodulin is
absent from the cornea but prominent in tendon, which con-
tains thicker collagen ¢brils. Possibly, the orchestrated action
of LRR-glycoproteins/proteoglycans may be important for
the generation of diverse collagen type I matrices.
Interestingly, the increased deposition of lumican in ¢bro-
modulin-null mice tendons leads to a considerable decrease in
lumican mRNA [25]. This indicates that ¢broblasts adjust the
synthesis of LRR-glycoproteins/proteoglycans in response to
the composition and/or structure of the extracellular matrix.
This regulation may involve unknown LRR-glycoprotein/pro-
teoglycan cell surface receptors or collagen receptors, such as
integrins [33,34] or DDR1/DDR2 tyrosine kinase receptors
[35].
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